Volume 7 Issue 267
Published - 14:00 UTC 08:00 EST 7-Oct-2005 
Next Update - 14:00 UTC 08:00 EST 8-Oct-2005

Editor: Susan K. Boyer, RN
© Vidyya.
All rights reserved.

We subscribe to the HONcode principles. Verify here.

  

 


Gold nanoparticles show potential for noninvasive cancer treatment

Researchers from the University of California, San Francisco and Georgia Institute of Technology have found a new way to kill cancer cells. Building on their previous work that used gold nanoparticles to detect cancer, they now are heating the particles and using them as agents to destroy malignant cells. more  

I think, therefore I fall

The patient came into the doctor's office in a wheelchair, weighted down by a diagnosis of Parkinson's disease, taking medication for the disorder and insisting she was unable to stand or walk. Thirty minutes later, after jogging down the hallway, she strolled out the door. more

Consensus panel calls for expanded role of needle biopsies, MRI and less invasive procedures

Physicians should strive to replace traditional, invasive procedures for diagnosing breast cancer with proven, less-invasive diagnostic methods, according to an international panel of breast cancer experts convened at the Keck School of Medicine of the University of Southern California. more  

Shift in brain's language-control site offers rehab hope

Scientists have found that the site in the brain that controls language in right-handed people shifts with aging--a discovery that might offer hope in the treatment of speech problems resulting from traumatic brain injury or stroke. more

Merck investigational vaccine GARDASIL prevented 100 percent of cervical pre- & non-invasive cancers  

GARDASIL(TM) (quadrivalent human papillomavirus types 6, 11, 16, 18, recombinant vaccine), an investigational vaccine from Merck & Co., Inc., prevented 100 percent of high-grade cervical pre-cancers and non-invasive cervical cancers (CIN 2/3 and AIS) associated with human papillomavirus (HPV) types 16 and 18 in a new phase III study. The analysis compared GARDASIL to placebo in women who were not infected with HPV 16 and 18 at enrollment and who remained free of infection through the completion of the vaccination regimen. Women were followed for an average of two years after enrollment. Tomorrow these data will be presented for the first time at the Infectious Diseases Society of America (IDSA) annual meeting. more

Prozac improves learning and memory in fatal brain disease 

Howard Florey Institute scientists in Melbourne have found that fluoxetine (commonly marketed as Prozac®) not only improves depression in Huntington's disease, but also improves learning and memory. more

Use of mon-COX-2-specific NSAIDs halves odds for oral cancer: doubles cardiovascular death risk

An analysis of 20 years of data on the health of over 900 adults has found that long-term use of traditional nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen and naproxen, cuts the risk for oral cancer in smokers by half. more

 

Physicians should strive to replace traditional, invasive procedures for diagnosing breast cancer with proven, less-invasive diagnostic methods